| Advice You |
Hubs | Hubbers | Topics | Request |
| #1 in Business | Subscribe Email Print |
|
You are here: Home > Business > Marketing > The Opportunity Lesson |
|
Advice You - The Opportunity Lesson
An opportunity is a chance or an opening in which we might be compelled to take some kind of action or make a movement towar According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product ds something we desire. We are provided with many opportunities doing our daily activities. We will normally only act or tak ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug. Examples of combination products may in e opportunities which are familiar to us. Opportunities provide us with a chance for change because taking opportunities pro lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together. vides a door towards greater growth. The more we look for opportunities, the more openings we will find. Looking for oppo here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe tunities will give us more chances for greater change to take place in our lives.
Seeing a greater number of opportunities d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations. Combination pro will help us to take the best course of action.
So, it is our job to be aware of our many doors of opportunity that presen ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc t themselves. When opportunities presents themselves to us, we must first evaluate the risks involved. If some people have easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi etermined the risk is to high; they will hesitate to take that particular opportunity. If an opportunity presents little ris nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically k to exposure or harm, we will readily move in such cases. Everyone has a different risk level during their evaluation proce and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ ss. We must all evaluate the risk that we are willing to take for our own selves. Our solutions have to be seen in the oppo ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi tunities that life gives us. We often look to see what will be the end result of certain opportunities. Even though, sometim ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it. Following aspects would a es the end result of an opportunity cannot be seen; it can only be perceived. We may decide that the chance is still worth t dd to the challenges in developing combination products: Which markets to tap where the combination products can do fairly well? Which combination prod he risk. The more opportunities we see in life, the more end results we can be perceived. Opportunities require that we mak cts are meaningful and rational? Which therapeutic categories to select? Which Combinations can address unmet needs of the patients? Do combin e or take some action to activate the process. We
can think about opportunities all day long, but if we take no action in tions increase the patient compliance? What would be the developing cost? How to tackle the risks encountered during combination product developmen his process, the opportunities in life will continue to pass us by. We need to have the strength and fortitude to make the r t? As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel equired actions or movements. If we have no strength, than we have no action. The optimum situation is for us to have the st ping new procedures for reviewing their safety, efficacy and quality. Professional from academic institutions, pharmaceutical industries, health care indust rength to make the necessary action towards our many life opportunities. Opportunities are something that we all have to wa y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products ch for in life. We have to realize that there are varying degrees of risk in all opportunities. We need to have the drive to . As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de move forward when our chances appear. Too many opportunities in life pass us by; we have to be ready for opportunities’ cal elopment. They need to be wiser in analyzing the market trends and the regulatory requirements. Companies that provide selfless information through particip l. We must make the best out of every opportunity. Our opportunities are similar to the wind, ever changing and ever present tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
Related Articles:Waitress at Marks & Spencer Saves Customer's Life
|